| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
44,261 |
39,711 |
$6.41M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
38,377 |
35,664 |
$5.63M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,338 |
11,732 |
$4.59M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27,190 |
24,063 |
$4.33M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
47,278 |
15,059 |
$3.05M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,276 |
14,711 |
$2.31M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
17,036 |
5,181 |
$2.20M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,032 |
9,998 |
$1.77M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
16,583 |
14,437 |
$1.75M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,624 |
8,841 |
$1.13M |
| G0378 |
Hospital observation service, per hour |
18,969 |
8,540 |
$1.10M |
| 70450 |
Computed tomography, head or brain; without contrast material |
11,861 |
10,686 |
$1.08M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,024 |
6,249 |
$1.07M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
29,147 |
23,461 |
$1.02M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,885 |
6,548 |
$960K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
40,992 |
31,021 |
$945K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
31,976 |
10,700 |
$941K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,827 |
6,437 |
$939K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
13,889 |
12,588 |
$925K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,264 |
1,222 |
$875K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,844 |
2,228 |
$787K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
10,316 |
10,185 |
$778K |
| S9485 |
Crisis intervention mental health services, per diem |
1,490 |
1,201 |
$747K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,325 |
3,971 |
$722K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,184 |
1,138 |
$643K |
| 59025 |
Fetal non-stress test |
2,451 |
1,476 |
$617K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
22,081 |
21,332 |
$605K |
| 99215 |
Prolong outpt/office vis |
4,514 |
3,320 |
$603K |
| 71046 |
Radiologic examination, chest; 2 views |
21,757 |
20,303 |
$589K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
21,538 |
20,804 |
$587K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
930 |
910 |
$577K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,189 |
4,573 |
$514K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,146 |
2,940 |
$431K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
2,827 |
2,599 |
$423K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,548 |
4,227 |
$421K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,504 |
3,278 |
$403K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
98,674 |
80,690 |
$398K |
| 87631 |
|
3,071 |
2,988 |
$349K |
| 93971 |
|
2,743 |
2,536 |
$347K |
| 97010 |
|
3,376 |
1,448 |
$345K |
| 76770 |
|
2,885 |
2,732 |
$337K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,967 |
3,699 |
$329K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,956 |
1,254 |
$317K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,450 |
3,165 |
$309K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
11,074 |
9,375 |
$305K |
| 84443 |
Thyroid stimulating hormone (TSH) |
33,490 |
32,161 |
$279K |
| 80053 |
Comprehensive metabolic panel |
82,476 |
72,255 |
$275K |
| 76642 |
|
2,868 |
2,610 |
$272K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16,730 |
16,208 |
$263K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
11,587 |
11,446 |
$263K |
| 97803 |
|
3,749 |
3,522 |
$248K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,184 |
2,073 |
$245K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
8,433 |
8,269 |
$223K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
10,560 |
10,432 |
$205K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,334 |
1,243 |
$203K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,675 |
9,270 |
$196K |
| 84702 |
|
16,114 |
13,583 |
$191K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
9,939 |
9,681 |
$187K |
| 97162 |
|
3,875 |
3,624 |
$180K |
| 85027 |
|
48,290 |
43,387 |
$179K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17,102 |
14,394 |
$178K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
32,920 |
30,065 |
$172K |
| 76536 |
|
1,528 |
1,473 |
$168K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
34,321 |
32,831 |
$157K |
| J3490 |
Unclassified drugs |
6,448 |
5,010 |
$148K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,087 |
2,902 |
$145K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,754 |
1,650 |
$145K |
| 80050 |
General health panel |
9,469 |
9,167 |
$144K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,045 |
2,963 |
$143K |
| 97161 |
|
3,409 |
3,098 |
$139K |
| 86780 |
|
12,521 |
12,173 |
$137K |
| 84484 |
|
19,591 |
15,483 |
$136K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
26,843 |
22,338 |
$131K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,454 |
1,785 |
$121K |
| ATP08 |
|
22,835 |
17,620 |
$118K |
| 93017 |
|
1,559 |
1,466 |
$116K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
427 |
416 |
$115K |
| 82607 |
|
14,213 |
13,656 |
$113K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
55,753 |
44,525 |
$111K |
| 80061 |
Lipid panel |
41,779 |
40,505 |
$111K |
| 86803 |
|
10,732 |
10,439 |
$111K |
| 86480 |
|
2,288 |
2,219 |
$108K |
| 82728 |
|
13,791 |
13,087 |
$107K |
| 77065 |
Tomosynthesis, mammo |
1,457 |
1,308 |
$106K |
| 93975 |
|
1,384 |
1,287 |
$106K |
| 76830 |
Ultrasound, transvaginal |
1,348 |
1,284 |
$103K |
| 73630 |
|
4,027 |
3,663 |
$101K |
| 0001A |
|
3,969 |
3,742 |
$92K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
634 |
604 |
$90K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,739 |
4,329 |
$87K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
29,507 |
15,164 |
$84K |
| 84466 |
|
11,458 |
10,933 |
$83K |
| 83880 |
|
7,304 |
6,247 |
$82K |
| 90834 |
Psychotherapy, 45 minutes with patient |
3,553 |
2,475 |
$81K |
| ATP14 |
|
15,529 |
13,300 |
$81K |
| 12001 |
|
433 |
401 |
$80K |
| 74018 |
|
2,145 |
1,983 |
$80K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
141 |
137 |
$79K |
| 83690 |
|
17,815 |
15,643 |
$78K |
| 87340 |
|
9,380 |
9,080 |
$76K |
| 73610 |
|
3,059 |
2,822 |
$74K |
| 87081 |
|
13,496 |
12,990 |
$73K |
| 72100 |
|
2,340 |
2,243 |
$73K |
| ATP15 |
|
9,887 |
7,599 |
$73K |
| 83735 |
|
21,209 |
15,729 |
$69K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
453 |
262 |
$68K |
| 97802 |
|
890 |
861 |
$68K |
| 86762 |
|
5,528 |
5,384 |
$68K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
3,356 |
3,176 |
$67K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
40,346 |
32,767 |
$65K |
| 84153 |
|
4,907 |
4,808 |
$65K |
| 71045 |
Radiologic examination, chest; single view |
12,054 |
10,840 |
$64K |
| 71250 |
|
1,469 |
1,358 |
$64K |
| 81003 |
|
47,982 |
43,392 |
$63K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
2,833 |
827 |
$62K |
| 0002A |
|
2,094 |
2,078 |
$60K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
369 |
350 |
$58K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
947 |
848 |
$57K |
| 77080 |
|
1,096 |
1,082 |
$56K |
| 84439 |
|
10,791 |
10,321 |
$55K |
| 85610 |
|
39,336 |
24,275 |
$55K |
| 84403 |
|
3,367 |
3,242 |
$54K |
| 83970 |
|
3,484 |
3,315 |
$54K |
| 81025 |
|
9,508 |
8,776 |
$51K |
| 73130 |
|
2,274 |
2,064 |
$49K |
| 87186 |
|
10,148 |
9,345 |
$49K |
| 87480 |
|
3,017 |
2,895 |
$49K |
| 87510 |
|
3,016 |
2,895 |
$48K |
| 87660 |
|
3,010 |
2,888 |
$48K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
228 |
211 |
$46K |
| 82805 |
|
1,176 |
1,063 |
$45K |
| 87077 |
|
9,683 |
8,927 |
$45K |
| J1756 |
Injection, iron sucrose, 1 mg |
711 |
333 |
$44K |
| 86618 |
|
3,808 |
3,671 |
$44K |
| 97116 |
|
2,289 |
1,302 |
$43K |
| 83540 |
|
12,027 |
11,478 |
$43K |
| 0011A |
|
1,205 |
1,181 |
$43K |
| 87088 |
|
8,406 |
7,894 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,720 |
3,593 |
$41K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,201 |
549 |
$41K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
3,978 |
1,647 |
$41K |
| 86850 |
|
6,027 |
5,464 |
$41K |
| 88342 |
|
2,325 |
2,198 |
$40K |
| 83516 |
|
2,156 |
1,971 |
$40K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,625 |
802 |
$40K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
241 |
38 |
$37K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
581 |
577 |
$37K |
| 73030 |
|
2,231 |
2,007 |
$37K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,239 |
8,419 |
$36K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
24 |
24 |
$36K |
| 87070 |
|
6,052 |
5,609 |
$35K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
453 |
417 |
$35K |
| 86140 |
|
11,981 |
10,324 |
$35K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,042 |
1,984 |
$34K |
| 71271 |
|
954 |
928 |
$34K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
118 |
112 |
$34K |
| ATP17 |
|
11,247 |
10,180 |
$34K |
| 73110 |
|
1,462 |
1,372 |
$33K |
| 84270 |
|
2,411 |
2,330 |
$32K |
| 85379 |
|
5,104 |
4,762 |
$32K |
| 82746 |
|
3,992 |
3,802 |
$32K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
10,178 |
7,969 |
$31K |
| 87040 |
|
3,297 |
2,794 |
$30K |
| 87147 |
|
4,813 |
4,523 |
$29K |
| 77066 |
Tomosynthesis, mammo |
292 |
290 |
$28K |
| 90715 |
|
1,438 |
1,340 |
$28K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
18,320 |
14,872 |
$27K |
| 83001 |
|
1,935 |
1,859 |
$27K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,391 |
14,343 |
$26K |
| 86787 |
|
2,377 |
2,293 |
$26K |
| 73502 |
|
1,296 |
1,206 |
$25K |
| 83021 |
|
1,635 |
1,588 |
$25K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
4,651 |
4,175 |
$25K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
372 |
358 |
$24K |
| 82248 |
|
23,435 |
19,992 |
$24K |
| 82784 |
|
3,122 |
2,967 |
$24K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
120 |
111 |
$24K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
706 |
669 |
$23K |
| 82947 |
|
6,957 |
6,752 |
$22K |
| 87522 |
Neg quan hep c or qual rna |
628 |
601 |
$22K |
| 84146 |
|
1,547 |
1,492 |
$21K |
| 93296 |
|
1,092 |
1,024 |
$21K |
| 82043 |
|
8,437 |
8,117 |
$19K |
| 83605 |
|
2,874 |
2,374 |
$19K |
| 83020 |
|
1,687 |
1,641 |
$18K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
361 |
324 |
$18K |
| 85730 |
|
6,119 |
5,508 |
$18K |
| 0012A |
|
528 |
525 |
$18K |
| 86038 |
|
2,181 |
2,104 |
$17K |
| 82570 |
|
6,211 |
5,675 |
$17K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,953 |
3,904 |
$16K |
| 94060 |
|
229 |
217 |
$16K |
| J1815 |
Injection, insulin, per 5 units |
2,822 |
888 |
$16K |
| 80076 |
|
5,820 |
5,447 |
$16K |
| 96367 |
|
306 |
253 |
$16K |
| 86900 |
|
6,016 |
5,434 |
$15K |
| 91300 |
|
2,212 |
1,924 |
$15K |
| 81514 |
|
158 |
147 |
$14K |
| 73560 |
|
731 |
611 |
$14K |
| 82550 |
|
3,726 |
3,143 |
$14K |
| 88304 |
|
1,058 |
997 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
88,983 |
66,814 |
$13K |
| 86706 |
|
1,821 |
1,762 |
$13K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,868 |
2,426 |
$13K |
| 87634 |
|
208 |
192 |
$12K |
| 73140 |
|
507 |
481 |
$12K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
432 |
422 |
$12K |
| 86901 |
|
6,009 |
5,430 |
$12K |
| 86704 |
|
1,454 |
1,406 |
$12K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,123 |
5,240 |
$12K |
| Q3014 |
Telehealth originating site facility fee |
5,026 |
4,556 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,714 |
2,377 |
$12K |
| ATP03 |
|
4,845 |
4,162 |
$12K |
| 76801 |
|
392 |
362 |
$11K |
| J2704 |
Injection, propofol, 10 mg |
14,425 |
10,839 |
$11K |
| 82670 |
|
519 |
478 |
$11K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
336 |
243 |
$11K |
| 85652 |
|
6,487 |
5,951 |
$11K |
| 12011 |
|
66 |
64 |
$11K |
| 82565 |
|
5,761 |
4,926 |
$11K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,353 |
8,655 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,967 |
1,410 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
77 |
76 |
$11K |
| ATP16 |
|
1,685 |
1,193 |
$10K |
| 87205 |
|
3,900 |
3,547 |
$10K |
| 73564 |
|
1,032 |
971 |
$10K |
| 82951 |
|
886 |
875 |
$10K |
| 84156 |
|
4,079 |
3,483 |
$10K |
| ATP07 |
|
2,008 |
1,799 |
$9K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,395 |
798 |
$9K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
9,350 |
8,652 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,746 |
7,098 |
$9K |
| 85004 |
|
4,396 |
3,665 |
$8K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,867 |
3,501 |
$8K |
| 80164 |
|
2,097 |
1,919 |
$8K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
54 |
52 |
$8K |
| 84550 |
|
8,325 |
6,645 |
$8K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,251 |
1,147 |
$7K |
| 81329 |
|
57 |
57 |
$7K |
| 94729 |
|
184 |
175 |
$7K |
| ATP05 |
|
997 |
757 |
$6K |
| 97597 |
|
69 |
40 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,048 |
3,439 |
$6K |
| 86364 |
|
703 |
681 |
$6K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
4,928 |
4,401 |
$6K |
| 84100 |
|
6,945 |
5,030 |
$6K |
| J0897 |
Injection, denosumab, 1 mg |
24 |
24 |
$6K |
| ATP11 |
|
1,916 |
1,695 |
$5K |
| 86258 |
|
473 |
471 |
$5K |
| 90791 |
Psychiatric diagnostic evaluation |
295 |
257 |
$5K |
| 82105 |
|
364 |
357 |
$5K |
| J2060 |
Injection, lorazepam, 2 mg |
3,662 |
2,929 |
$5K |
| 87625 |
|
212 |
209 |
$5K |
| 83037 |
|
1,809 |
1,595 |
$5K |
| 80178 |
|
1,616 |
1,426 |
$5K |
| 99218 |
|
271 |
159 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
43 |
40 |
$5K |
| 84480 |
|
530 |
508 |
$5K |
| 86141 |
|
546 |
505 |
$5K |
| ATP18 |
|
2,060 |
1,806 |
$5K |
| 80159 |
|
764 |
632 |
$5K |
| 82150 |
|
1,073 |
971 |
$4K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
797 |
283 |
$4K |
| 83002 |
|
321 |
292 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
299 |
271 |
$4K |
| 84145 |
|
2,374 |
2,027 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
397 |
219 |
$4K |
| 84460 |
|
4,426 |
3,785 |
$4K |
| 70486 |
|
101 |
100 |
$4K |
| 97165 |
|
54 |
52 |
$4K |
| 81508 |
|
113 |
107 |
$4K |
| 88341 |
|
172 |
157 |
$4K |
| 84450 |
|
4,275 |
3,615 |
$4K |
| 70498 |
|
40 |
39 |
$3K |
| 87150 |
|
406 |
401 |
$3K |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
2,422 |
1,712 |
$3K |
| 86431 |
|
704 |
691 |
$3K |
| 85014 |
|
2,117 |
1,848 |
$3K |
| 76870 |
|
38 |
36 |
$3K |
| 87427 |
|
237 |
219 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
9,116 |
7,935 |
$3K |
| 85018 |
|
1,948 |
1,686 |
$3K |
| 80179 |
|
234 |
229 |
$3K |
| 84520 |
|
4,080 |
3,380 |
$3K |
| 74183 |
|
13 |
12 |
$3K |
| ATP10 |
|
1,023 |
905 |
$3K |
| 82952 |
|
732 |
721 |
$2K |
| 82077 |
|
774 |
695 |
$2K |
| 86696 |
|
106 |
104 |
$2K |
| 97163 |
|
43 |
41 |
$2K |
| 82962 |
|
20,420 |
13,267 |
$2K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
532 |
298 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,999 |
1,221 |
$2K |
| 86695 |
|
118 |
116 |
$2K |
| 12002 |
|
14 |
13 |
$2K |
| ATP04 |
|
436 |
394 |
$2K |
| 87046 |
|
239 |
221 |
$2K |
| 74019 |
|
133 |
124 |
$2K |
| 87420 |
|
167 |
161 |
$2K |
| ATP09 |
|
302 |
247 |
$2K |
| 87449 |
|
289 |
262 |
$2K |
| 86160 |
|
90 |
79 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
40 |
37 |
$1K |
| 84165 |
|
331 |
317 |
$1K |
| 70496 |
|
30 |
25 |
$1K |
| 86308 |
|
353 |
329 |
$1K |
| 84163 |
|
92 |
90 |
$1K |
| 87045 |
|
222 |
207 |
$1K |
| 83520 |
|
114 |
109 |
$1K |
| 90686 |
|
203 |
187 |
$1K |
| 72141 |
|
12 |
12 |
$1K |
| 36591 |
|
389 |
255 |
$1K |
| 83921 |
|
82 |
79 |
$1K |
| 87536 |
|
38 |
38 |
$1K |
| 73080 |
|
95 |
93 |
$1K |
| 71101 |
|
115 |
106 |
$1K |
| 84681 |
|
77 |
76 |
$1K |
| 87210 |
|
313 |
298 |
$1K |
| 98968 |
|
13 |
12 |
$1K |
| 84425 |
|
67 |
66 |
$1K |
| 86360 |
|
111 |
107 |
$1K |
| 82677 |
|
54 |
54 |
$1K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
707 |
178 |
$1K |
| 97035 |
|
20 |
13 |
$1K |
| 84436 |
|
304 |
294 |
$1K |
| 82533 |
|
80 |
80 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,384 |
14,475 |
$1K |
| 84134 |
|
105 |
101 |
$1K |
| 87015 |
|
181 |
165 |
$998.21 |
| 86355 |
|
124 |
119 |
$967.80 |
| 83721 |
|
234 |
223 |
$957.09 |
| 87272 |
|
110 |
107 |
$953.62 |
| 87269 |
|
98 |
95 |
$916.99 |
| 72050 |
|
26 |
25 |
$889.73 |
| 86336 |
|
54 |
54 |
$888.16 |
| 87102 |
|
145 |
138 |
$886.38 |
| 86359 |
|
111 |
107 |
$864.54 |
| 86357 |
|
111 |
107 |
$864.54 |
| 73590 |
|
62 |
54 |
$829.59 |
| 87324 |
|
166 |
150 |
$825.22 |
| 83655 |
|
70 |
70 |
$824.52 |
| ATP02 |
|
318 |
262 |
$808.61 |
| 99442 |
|
138 |
118 |
$801.66 |
| 86200 |
|
75 |
75 |
$776.81 |
| 70491 |
|
13 |
12 |
$762.22 |
| 80069 |
|
877 |
792 |
$762.15 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
114 |
61 |
$729.41 |
| 86769 |
|
26 |
25 |
$702.42 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,081 |
3,495 |
$694.54 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
412 |
233 |
$686.14 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
589 |
528 |
$673.92 |
| 82390 |
|
83 |
78 |
$619.28 |
| G0008 |
Administration of influenza virus vaccine |
351 |
343 |
$605.68 |
| 88307 |
|
39 |
39 |
$555.18 |
| 84481 |
|
39 |
39 |
$537.84 |
| 83090 |
|
37 |
37 |
$517.11 |
| 36000 |
|
52 |
43 |
$511.32 |
| 85045 |
|
247 |
220 |
$489.04 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
2,239 |
2,212 |
$474.25 |
| 82140 |
|
145 |
113 |
$466.65 |
| 83718 |
|
81 |
79 |
$460.47 |
| 97166 |
|
16 |
12 |
$457.12 |
| 11721 |
|
24 |
24 |
$426.76 |
| 86677 |
|
45 |
41 |
$420.69 |
| 84630 |
|
51 |
50 |
$417.73 |
| 86665 |
|
13 |
13 |
$416.00 |
| 72072 |
|
13 |
12 |
$413.91 |
| 83615 |
|
768 |
652 |
$375.04 |
| 82272 |
|
263 |
244 |
$374.09 |
| 82948 |
|
108 |
98 |
$368.52 |
| 86376 |
|
43 |
37 |
$362.94 |
| 86666 |
|
18 |
16 |
$359.36 |
| A4217 |
Sterile water/saline, 500 ml |
69 |
66 |
$343.07 |
| 87641 |
|
44 |
41 |
$340.42 |
| J1630 |
Injection, haloperidol, up to 5 mg |
215 |
167 |
$339.64 |
| 96376 |
|
3,141 |
2,724 |
$338.62 |
| 99443 |
|
43 |
37 |
$307.56 |
| 82610 |
|
24 |
24 |
$303.53 |
| 88112 |
|
12 |
12 |
$299.58 |
| 83883 |
|
43 |
39 |
$286.62 |
| 87640 |
|
44 |
41 |
$278.53 |
| 82270 |
|
189 |
170 |
$260.28 |
| 82247 |
|
68 |
39 |
$252.51 |
| 82040 |
|
421 |
410 |
$240.71 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
163 |
89 |
$229.43 |
| 84590 |
|
28 |
27 |
$227.60 |
| 86708 |
|
24 |
24 |
$206.95 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
3,233 |
3,015 |
$197.33 |
| 80143 |
|
90 |
85 |
$197.28 |
| 93246 |
|
26 |
25 |
$193.50 |
| 86664 |
|
13 |
13 |
$188.86 |
| 90662 |
|
91 |
88 |
$162.18 |
| 73552 |
|
14 |
12 |
$148.85 |
| 84132 |
|
280 |
219 |
$144.59 |
| 82525 |
|
12 |
12 |
$131.40 |
| 82010 |
|
30 |
24 |
$109.90 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
30 |
27 |
$94.98 |
| 87207 |
|
21 |
19 |
$91.41 |
| 86709 |
|
13 |
13 |
$79.44 |
| 80156 |
|
14 |
13 |
$75.15 |
| 73660 |
|
14 |
12 |
$73.55 |
| 82378 |
|
14 |
13 |
$58.68 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
13 |
12 |
$46.30 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
3,087 |
2,872 |
$43.30 |
| 82310 |
|
26 |
25 |
$36.18 |
| 82977 |
|
17 |
13 |
$14.84 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
334 |
298 |
$8.46 |
| 99152 |
|
212 |
203 |
$5.22 |
| 99153 |
Mod sedat endo service >5yrs |
318 |
300 |
$4.17 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
220 |
220 |
$3.29 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
2,780 |
1,617 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
4,819 |
3,395 |
$0.00 |
| G0177 |
Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) |
766 |
144 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
149 |
139 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
274 |
263 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,558 |
853 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
106 |
102 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
555 |
506 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
632 |
569 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
114 |
87 |
$0.00 |
| 76942 |
|
12 |
12 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
44 |
40 |
$0.00 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
17 |
14 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
13 |
12 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
31 |
29 |
$0.00 |
| 36592 |
|
47 |
26 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
75 |
54 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
629 |
536 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
81 |
74 |
$0.00 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
85 |
85 |
$0.00 |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
311 |
54 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
196 |
179 |
$0.00 |
| 91301 |
|
1,177 |
1,149 |
$0.00 |
| C1769 |
Guide wire |
161 |
151 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
82 |
54 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
15 |
12 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
29 |
29 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
14 |
12 |
$0.00 |